Abstract: The access method includes the following steps. Firstly, multimedia data is accessed with a multimedia access device located on a local network, which connected to a public network via a network address translation (NAT) or firewall device. Next, first communication link between a portal server and the multimedia access device is established. Then a piece of punch-through information indicating whether the multimedia access device can punch through the NAT/firewall device is obtained in response to an inquiry command provided by a client device. Next, when the multimedia access device cannot punch through the NAT/firewall device, the multimedia data is pushed from the multimedia access device to the portal server and the multimedia data pushed to the portal server is further pulled from the portal server to the client device, so that multimedia data transmission between the client device and the multimedia access device can be obtained.

Abstract: The present invention provides a compound of the formula: a pharmaceutically acceptable salt or a prodrug thereof, where R1, R2, R3, R4, R5, R6, R7, R8, R9, Y, Z1, m, n, and p are as defined herein. The present invention also provides compositions comprising, methods for using, and methods for preparing Compound of Formula I.

Abstract: A video recording method is provided. The method includes steps of: determining a threshold bit rate according to a storage space and an expected recording period; capturing a video data; determining whether a current bit rate is greater than the threshold bit rate; storing a predictive frame of the video data when the current bit rate is not greater than the threshold bit rate; and not storing the predictive frame when the current bit rate is greater than the threshold bit rate.

Abstract: A motion detection method is provided. The method includes steps of: capturing a current frame, generating a current luma frame according to the current frame, generating a foreground binary image according to the current luma frame, a background luma image and a sensitivity, and updating the background luma frame according to an updating frequency and the sensitivity.

Abstract: The present invention provides a compound of the formula: a pharmaceutically acceptable salt or a prodrug thereof, where R1, R2, R3, R4, R5, R6, R7, R8, R9, Y, Z1, m, n, and p are as defined herein. The present invention also provides compositions comprising, methods for using, and methods for preparing Compound of Formula I.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4, R5 and Ra are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4, R5 and Ra are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

Abstract: The present invention provides compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: A mobile terminal as well as a network connecting method and a network connecting apparatus thereof are disclosed in the present disclosure. The network connecting method comprises the following steps of: determining whether the network connecting mode is a dual-mode mode when the mobile terminal is connecting to a network; and if it is determined that the network connecting mode is the dual-mode mode, then setting the network connecting mode of the mobile terminal into a TD preference mode and connecting to the network. In the present disclosure, when the mobile phone is not in a 3G network or when the 3G signal is weak, the mobile phone that has been switched to a 2G network can re-initiate the network business without the need of firstly logging on the 3G network. This significantly reduces the network searching time, which is very convenient for the user.

Abstract: A monitoring system for a mobile terminal is disclosed in the present disclosure. The monitoring system comprises: a monitoring mobile terminal, being configured to send monitoring request information; and at least one monitored mobile terminal, being configured to receive the monitoring request information and send a corresponding monitoring report to the monitoring mobile terminal according to the monitoring request information. The monitoring mobile terminal and the monitored mobile terminal are connected wirelessly.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, R1, R2, R3, R4, R5 and R6 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

Abstract: The present invention provides compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: Methods and apparatus to provide a modular native method invocation (NMI) system are described herein. In an example method, first NMI information associated with a first NMI call from a first virtual machine is received and second NMI information associated with a second NMI call from a second virtual machine different from the first virtual machine is received. The first NMI information and the second NMI information is translated via an NMI adapter. To generate a native stub, the translated NMI information is provided to a modular NMI component.

Abstract: The invention provides a local search method for a handset, comprising the following steps: step a, loading a handset to a local browser and a local database, and prompting the user to input a retrieval word; step b, displaying a search result and listing a function list based on the retrieval word input by the user. The local search method for a handset provided by the present invention obtains all the function titles related to the keywords by searching the local database using the local browser and displays them in a display list of the browser. The user may choose to perform a corresponding function directly, so it greatly facilitates the user.

Abstract: The access method includes the following steps. Firstly, multimedia data is accessed with a multimedia access device located on a local network, which connected to a public network via a network address translation (NAT) or firewall device. Next, first communication link between a portal server and the multimedia access device is established. Then a piece of punch-through information indicating whether the multimedia access device can punch through the NAT/firewall device is obtained in response to an inquiry command provided by a client device. Next, when the multimedia access device cannot punch through the NAT/firewall device, the multimedia data is pushed from the multimedia access device to the portal server and the multimedia data pushed to the portal server is further pulled from the portal server to the client device, so that multimedia data transmission between the client device and the multimedia access device can be obtained.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, p, q, Ar, R1, R2, R3 and R4 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.

Abstract: Compounds of the formula I: wherein m, n, p, X, Ar, R1, R2, R3, R4 and R5 are as defined herein. Methods of making the compounds and using the compounds for treatment of 5-HT6 receptor-mediated diseases are disclosed.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4, R5 and Ra are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4, R5 and Ra are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.